8-K/A filed September 13, 2021, 7:59 PM ET ticker CVSA CIK 0000730464

leadership confidence high sentiment neutral materiality 0.60

Adtalem CEO Lisa Wardell transitions to Executive Chairman; Group President departs

Covista Inc.

Lisa W. Wardell transitions from CEO/President to Executive Chairman effective Sept 8, 2021; will lead strategic review of Financial Services business.
Wardell enters employment agreement with base salary $1.1M through Sept 7, 2022; eligibility for severance with double trigger change in control.
Kathy Boden Holland, Group President Medical & Healthcare, to leave Sept 30, 2021; terms of departure not yet determined.
Wardell's duties include furthering Global Legislative Agenda; she continues as Board Chair.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Lisa W. Wardell

Executive Chairman

CVSA · Covista Inc.

Effective: 2021-09-08
Filed: September 13, 2021, 7:59 PM ET

effective September 8, 2021, Ms. Lisa W. Wardell, who has served as ATGE’s president and chief executive officer since May 24, 2016 and chairman of the board since July 16, 2019, will transition to the role of executive chairman of the Board.

Departed

Kathy Boden Holland

Group President, ATGE Medical and Healthcare

CVSA · Covista Inc.

Effective: 2021-09-30
Filed: September 13, 2021, 7:59 PM ET

On September 7, 2021 it was announced that Ms. Kathy Boden Holland, Group President, ATGE Medical and Healthcare, will leave the Company on September 30, 2021 to pursue other endeavors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lisa W. Wardell changed role as Executive Chairman at Covista Inc..

Action: transitioned
Role: Executive Chairman

Exact text from the filing

effective September 8, 2021, Ms. Lisa W. Wardell, who has served as ATGE’s president and chief executive officer since May 24, 2016 and chairman of the board since July 16, 2019, will transition to the role of executive chairman of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathy Boden Holland departed as Group President, ATGE Medical and Healthcare at Covista Inc..

Action: will leave
Role: Group President, ATGE Medical and Healthcare

Exact text from the filing

On September 7, 2021 it was announced that Ms. Kathy Boden Holland, Group President, ATGE Medical and Healthcare, will leave the Company on September 30, 2021 to pursue other endeavors.

View on SEC.gov

Covista Inc. filing history →

Source: SEC EDGAR

accession 0001157523-21-001137

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.